Matrix metalloproteinases

Protective roles in cancer

Julie Decock, Sally Thirkettle, Laura Wagstaff, Dylan R. Edwards

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

• Introduction • MMP-3 • MMP-8 • MMP-9 • MMP-12 • MMP-19 • MMP-26 • Conclusions The original notion that matrix metalloproteinases (MMPs) act as tumour and metastasis-promoting enzymes by clearing a path for tumour cells to invade and metastasize has been challenged in the last decade. It has become clear that MMPs are involved in numerous steps of tumour progression and metastasis, and hence are now considered to be multifaceted proteases. Moreover, more recent experimental evidence indicates that some members of the MMP family behave as tumour-suppressor enzymes and should therefore be regarded as anti-targets in cancer therapy. The complexity of the pro- and anti-tumorigenic and -metastatic functions might partly explain why broad-spectrum MMP inhibitors failed in phase III clinical trials. This review will provide a focussed overview of the published data on the tumour-suppressive behaviour of MMPs.

Original languageEnglish
Pages (from-to)1254-1265
Number of pages12
JournalJournal of Cellular and Molecular Medicine
Volume15
Issue number6
DOIs
Publication statusPublished - 1 Jun 2011
Externally publishedYes

Fingerprint

Matrix Metalloproteinases
Neoplasms
Matrix Metalloproteinase 12
Matrix Metalloproteinase 8
Neoplasm Metastasis
Matrix Metalloproteinase 3
Phase III Clinical Trials
Matrix Metalloproteinase Inhibitors
Matrix Metalloproteinase 9
Enzymes
Peptide Hydrolases

Keywords

  • Anti-target
  • Cancer
  • Matrix metalloproteinases
  • Protective

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Medicine

Cite this

Matrix metalloproteinases : Protective roles in cancer. / Decock, Julie; Thirkettle, Sally; Wagstaff, Laura; Edwards, Dylan R.

In: Journal of Cellular and Molecular Medicine, Vol. 15, No. 6, 01.06.2011, p. 1254-1265.

Research output: Contribution to journalArticle

Decock, Julie ; Thirkettle, Sally ; Wagstaff, Laura ; Edwards, Dylan R. / Matrix metalloproteinases : Protective roles in cancer. In: Journal of Cellular and Molecular Medicine. 2011 ; Vol. 15, No. 6. pp. 1254-1265.
@article{9dff405f553e45baa55e45bb4b9126b5,
title = "Matrix metalloproteinases: Protective roles in cancer",
abstract = "• Introduction • MMP-3 • MMP-8 • MMP-9 • MMP-12 • MMP-19 • MMP-26 • Conclusions The original notion that matrix metalloproteinases (MMPs) act as tumour and metastasis-promoting enzymes by clearing a path for tumour cells to invade and metastasize has been challenged in the last decade. It has become clear that MMPs are involved in numerous steps of tumour progression and metastasis, and hence are now considered to be multifaceted proteases. Moreover, more recent experimental evidence indicates that some members of the MMP family behave as tumour-suppressor enzymes and should therefore be regarded as anti-targets in cancer therapy. The complexity of the pro- and anti-tumorigenic and -metastatic functions might partly explain why broad-spectrum MMP inhibitors failed in phase III clinical trials. This review will provide a focussed overview of the published data on the tumour-suppressive behaviour of MMPs.",
keywords = "Anti-target, Cancer, Matrix metalloproteinases, Protective",
author = "Julie Decock and Sally Thirkettle and Laura Wagstaff and Edwards, {Dylan R.}",
year = "2011",
month = "6",
day = "1",
doi = "10.1111/j.1582-4934.2011.01302.x",
language = "English",
volume = "15",
pages = "1254--1265",
journal = "Journal of Cellular and Molecular Medicine",
issn = "1582-1838",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Matrix metalloproteinases

T2 - Protective roles in cancer

AU - Decock, Julie

AU - Thirkettle, Sally

AU - Wagstaff, Laura

AU - Edwards, Dylan R.

PY - 2011/6/1

Y1 - 2011/6/1

N2 - • Introduction • MMP-3 • MMP-8 • MMP-9 • MMP-12 • MMP-19 • MMP-26 • Conclusions The original notion that matrix metalloproteinases (MMPs) act as tumour and metastasis-promoting enzymes by clearing a path for tumour cells to invade and metastasize has been challenged in the last decade. It has become clear that MMPs are involved in numerous steps of tumour progression and metastasis, and hence are now considered to be multifaceted proteases. Moreover, more recent experimental evidence indicates that some members of the MMP family behave as tumour-suppressor enzymes and should therefore be regarded as anti-targets in cancer therapy. The complexity of the pro- and anti-tumorigenic and -metastatic functions might partly explain why broad-spectrum MMP inhibitors failed in phase III clinical trials. This review will provide a focussed overview of the published data on the tumour-suppressive behaviour of MMPs.

AB - • Introduction • MMP-3 • MMP-8 • MMP-9 • MMP-12 • MMP-19 • MMP-26 • Conclusions The original notion that matrix metalloproteinases (MMPs) act as tumour and metastasis-promoting enzymes by clearing a path for tumour cells to invade and metastasize has been challenged in the last decade. It has become clear that MMPs are involved in numerous steps of tumour progression and metastasis, and hence are now considered to be multifaceted proteases. Moreover, more recent experimental evidence indicates that some members of the MMP family behave as tumour-suppressor enzymes and should therefore be regarded as anti-targets in cancer therapy. The complexity of the pro- and anti-tumorigenic and -metastatic functions might partly explain why broad-spectrum MMP inhibitors failed in phase III clinical trials. This review will provide a focussed overview of the published data on the tumour-suppressive behaviour of MMPs.

KW - Anti-target

KW - Cancer

KW - Matrix metalloproteinases

KW - Protective

UR - http://www.scopus.com/inward/record.url?scp=79957651592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957651592&partnerID=8YFLogxK

U2 - 10.1111/j.1582-4934.2011.01302.x

DO - 10.1111/j.1582-4934.2011.01302.x

M3 - Article

VL - 15

SP - 1254

EP - 1265

JO - Journal of Cellular and Molecular Medicine

JF - Journal of Cellular and Molecular Medicine

SN - 1582-1838

IS - 6

ER -